3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
96
Head and Neck Neoplasms
78
Carcinoma, Non-Small-Cell Lung
16
Oropharyngeal Neoplasms
13
Mouth Neoplasms
11
Carcinoma, Squamous Cell
11
Thyroid Carcinoma, Anaplastic
10
Neoplasm Metastasis
10
Thyroid Neoplasms
9
Salivary Gland Neoplasms
9
Recurrence
9
Hypopharyngeal Neoplasms
9
Carcinoma
9
Neoplasms
8
Nasopharyngeal Neoplasms
8
Nasopharyngeal Carcinoma
8
Melanoma
8
Laryngeal Neoplasms
8
Ovarian Neoplasms
7
Lung Neoplasms
7
Breast Neoplasms
7
Endometrial Neoplasms
6
Uterine Cervical Neoplasms
5
Stomach Neoplasms
5
Colorectal Neoplasms
5
Small Cell Lung Carcinoma
4
Esophageal Neoplasms
4
Carcinoma, Transitional Cell
4
Carcinoma, Ovarian Epithelial
4
Tongue Neoplasms
3
Interventions
selpercatinib
2
pralsetinib
2
repotrectinib
1
pembrolizumab
1
alectinib
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Respiratory Tract Diseases
×
Paclitaxel
×
Head & Neck
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts